These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8387321)

  • 21. [Intravesical Recurrence of Small Cell Carcinoma of the Ureter: A Case Report].
    Ueda N; Kobayashi Y; Arai H; Honda M; Yoshida K
    Hinyokika Kiyo; 2016 Feb; 62(2):93-7. PubMed ID: 27018413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ifosfamide in soft tissue sarcoma.
    Zaidi SH; Iqbal Z; Mallick JA
    J Pak Med Assoc; 1990 Sep; 40(9):222-4. PubMed ID: 2123272
    [No Abstract]   [Full Text] [Related]  

  • 23. Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: an EORTC Phase III trial.
    Postmus PE; Scagliotti G; Groen HJ; Gozzelino F; Burghouts JT; Curran D; Sahmoud T; Kirkpatrick A; Giaccone G; Splinter TA
    Eur J Cancer; 1996 Aug; 32A(9):1498-503. PubMed ID: 8911108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pilot study of ambulatory infusional delivery of a multidrug regimen: ifosfamide, carboplatin and etoposide (ICE).
    Lokich J; Anderson N; Moore C; Bern M; Coco F; Dow E
    J Infus Chemother; 1996; 6(1):39-42. PubMed ID: 8748006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II study of ifosfamide, carboplatin, etoposide and GM-CSF in small cell lung cancer.
    Thongprasert S
    J Med Assoc Thai; 2000 May; 83(5):549-53. PubMed ID: 10863902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase II study of the combination of carboplatin and ifosfamide in previously untreated metastatic small cell lung carcinoma.
    Le Chevalier T; Thomas F; Subirana R; Baldeyrou P; Ruffie P; Arriagada R; Chazard M; Tursz T
    Cancer; 1991 Jun; 67(12):2980-3. PubMed ID: 1646067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ifosfamide- and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma.
    Mayer J; Vásová I; Korístek Z; Navrátil M; Klabusay M; Doubek M; Vorlícek J; Cernilová I; Vodvárka P; Petráková K
    Eur J Haematol Suppl; 2001 Jul; 64():21-7. PubMed ID: 11486396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
    Ettinger DS
    Semin Oncol; 1995 Feb; 22(1 Suppl 2):23-7. PubMed ID: 7846538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ifosfamide, carboplatin and etoposide for good prognosis small cell lung cancer: are four courses inadequate? West of Scotland Lung Cancer Group.
    Hatton MQ; Cassidy J; Bicknell S; Semple P; Stack B; Steward WP
    Eur J Cancer; 1995 Jun; 31A(6):1022-3. PubMed ID: 7646904
    [No Abstract]   [Full Text] [Related]  

  • 30. Two schedules of application for mesna and their influence on the thiol-metabolism.
    Kempgens B; Kisro J; Gruber Y; Bahrs H; Wagner T
    Int J Clin Pharmacol Ther; 2003 Dec; 41(12):608-9. PubMed ID: 14692714
    [No Abstract]   [Full Text] [Related]  

  • 31. Dose intensity phase I/II trial with carboplatin, ifosfamide, etoposide and vincristine combined with filgrastim in patients with small-cell lung cancer.
    Hanauske AR; Korfel A; Perker M; Heinrich B; Schwab G; Graf M; Depenbrock H; Höffken G; Kreuser ED; Thiel E; Zwingers T; Berdel WE
    Oncology; 1997; 54(5):363-70. PubMed ID: 9260596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
    Chang AY; Boros L; Garrow GC; Asbury RF; Hui L
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):74-7. PubMed ID: 8677454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of secondary malignant lymphoma of the urinary bladder].
    Yokoyama M; Kobayashi T; Kubo Y; Kageyama Y; Kihara K
    Hinyokika Kiyo; 2006 Apr; 52(4):285-7. PubMed ID: 16686357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-cycle, high-dose ifosfamide, carboplatin, and etoposide followed by peripheral blood stem-cell transplantation for small cell lung cancer.
    Iwasaki Y; Nagata K; Nakanishi M; Natuhara A; Kubota Y; Ueda M; Arimoto T; Hara H
    Chest; 2005 Oct; 128(4):2268-73. PubMed ID: 16236883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support.
    Lotz JP; Izrael V
    Bone Marrow Transplant; 1995 Dec; 16(6):858-9. PubMed ID: 8750286
    [No Abstract]   [Full Text] [Related]  

  • 36. Diseases desperate grown.
    Bunn PA
    J Natl Cancer Inst; 2008 Apr; 100(8):520-1. PubMed ID: 18398099
    [No Abstract]   [Full Text] [Related]  

  • 37. Introduction to ifosfamide/carboplatin/etoposide chemotherapy.
    Chang AY
    Semin Oncol; 1995 Jun; 22(3 Suppl 7):1-4. PubMed ID: 7610393
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful management of small cell carcinoma of the bladder with cisplatin and etoposide.
    Davis MP; Murthy MS; Simon J; Wise H; Minton JP
    J Urol; 1989 Sep; 142(3):817. PubMed ID: 2549274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancer.
    Lorigan P; Lee SM; Betticher D; Woodhead M; Weir D; Hanley S; Hardy C; Thatcher N
    Semin Oncol; 1995 Jun; 22(3 Suppl 7):32-41. PubMed ID: 7610397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer.
    Strauss GM; Lynch TJ; Elias AD; Jacobs C; Kwiatkowski DJ; Shulman LN; Carey RW; Grossbard ML; Jauss S; Sugarbaker DJ
    Semin Oncol; 1995 Aug; 22(4 Suppl 9):70-4. PubMed ID: 7544029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.